
Pharma Pulse 12/6/24: Advantages of New Medicare Rx Payment Plan, Stigma Against Smokers Among Future Healthcare Providers & more
The latest news for pharma industry insiders.
While the program could be a good option for many, it's not a panacea.
Patients and their caregivers might benefit from being aware of the stigma to advocate for compassionate, optimal care.
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.
Aktana, Inc., the leader in intelligent customer engagement for the global life sciences industry, today announced the Aktana Action Agent - designed to empower field teams and future-proof omnichannel engagement.
Patients do not want to be defined by their therapies (or as widgets) but as individuals.
Conversation between William Grambley and Miranda Schmalfuhs about using AI to predict and influence patient behavior, adherence and ethical implications
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

